92 related articles for article (PubMed ID: 9280669)
1. [Pharmacotherapeutical perspectives in Alzheimer's disease].
Martínez-Lage JM
Rev Neurol; 1997 Jul; 25 Suppl 1():S63-9. PubMed ID: 9280669
[No Abstract] [Full Text] [Related]
2. Impaired muscarinic regulation of excitatory synaptic transmission in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
Goto Y; Niidome T; Hongo H; Akaike A; Kihara T; Sugimoto H
Eur J Pharmacol; 2008 Mar; 583(1):84-91. PubMed ID: 18282567
[TBL] [Abstract][Full Text] [Related]
3. Advances in understanding the pathogenetic mechanisms of Alzheimer's disease.
Govoni S; Lanni C; Racchi M
Funct Neurol; 2001; 16(4 Suppl):17-30. PubMed ID: 11996513
[No Abstract] [Full Text] [Related]
4. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity.
Varadarajan S; Yatin S; Aksenova M; Butterfield DA
J Struct Biol; 2000 Jun; 130(2-3):184-208. PubMed ID: 10940225
[TBL] [Abstract][Full Text] [Related]
5. [Alzheimer's disease: therapeutic perspectives].
Dubois B; De Souza L; Allali G; Kalafat M; Sarazin M
Bull Acad Natl Med; 2008 Feb; 192(2):333-42; discussion 343-4. PubMed ID: 18819687
[TBL] [Abstract][Full Text] [Related]
6. Chronically mad as a hatter: anticholinergics and Alzheimer's disease pathology.
Levey AI
Ann Neurol; 2003 Aug; 54(2):144-6. PubMed ID: 12891665
[No Abstract] [Full Text] [Related]
7. The role of nicotinic acetylcholine receptors in Alzheimer's disease.
Oddo S; LaFerla FM
J Physiol Paris; 2006; 99(2-3):172-9. PubMed ID: 16448808
[TBL] [Abstract][Full Text] [Related]
8. Alteration of peripheral markers of copper homeostasis in Alzheimer's disease patients: implications in aetiology and therapy.
Rossi L; Squitti R; Calabrese L; Rotilio G; Rossini PM
J Nutr Health Aging; 2007; 11(5):408-17. PubMed ID: 17657362
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease: the cholesterol connection.
Puglielli L; Tanzi RE; Kovacs DM
Nat Neurosci; 2003 Apr; 6(4):345-51. PubMed ID: 12658281
[TBL] [Abstract][Full Text] [Related]
10. [Amyloid cascade hypothesis of Alzheimer's disease and alpha 7 nicotinic receptor].
Hashimoto K; Iyo M
Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Apr; 22(2):49-53. PubMed ID: 12050852
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic options in Alzheimer's disease.
Moreira PI; Zhu X; Nunomura A; Smith MA; Perry G
Expert Rev Neurother; 2006 Jun; 6(6):897-910. PubMed ID: 16784412
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice.
Tong XK; Nicolakakis N; Fernandes P; Ongali B; Brouillette J; Quirion R; Hamel E
Neurobiol Dis; 2009 Sep; 35(3):406-14. PubMed ID: 19524673
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk between oxidative stress and modifications of cholinergic and glutaminergic receptors in the pathogenesis of Alzheimer's disease.
Guan ZZ
Acta Pharmacol Sin; 2008 Jul; 29(7):773-80. PubMed ID: 18565274
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease therapeutics: new approaches to an ageing problem.
Small DH; Losic D; Martin LL; Turner BJ; Friedhuber A; Aguilar MI
IUBMB Life; 2004 Apr; 56(4):203-8. PubMed ID: 15230347
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of oxidant mechanisms in Alzheimer's disease.
Moreira PI; Smith MA; Zhu X; Santos MS; Oliveira CR; Perry G
Expert Rev Neurother; 2004 Nov; 4(6):995-1004. PubMed ID: 15853526
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Alzheimer's disease: from pharmacology to a better understanding of disease pathophysiology.
Silvestrelli G; Lanari A; Parnetti L; Tomassoni D; Amenta F
Mech Ageing Dev; 2006 Feb; 127(2):148-57. PubMed ID: 16278007
[TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease.
Pedersen WA; McCullers D; Culmsee C; Haughey NJ; Herman JP; Mattson MP
Neurobiol Dis; 2001 Jun; 8(3):492-503. PubMed ID: 11442356
[TBL] [Abstract][Full Text] [Related]
18. [Inflammatory mechanisms in the pathogenesis of Alzheimer's disease].
Verbeek MM; Otte-Höller I; Ruiter DJ; de Waal RM
Tijdschr Gerontol Geriatr; 1997 Oct; 28(5):213-8. PubMed ID: 9526791
[TBL] [Abstract][Full Text] [Related]
19. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes.
Blasko I; Stampfer-Kountchev M; Robatscher P; Veerhuis R; Eikelenboom P; Grubeck-Loebenstein B
Aging Cell; 2004 Aug; 3(4):169-76. PubMed ID: 15268750
[TBL] [Abstract][Full Text] [Related]
20. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
Grossberg GT; Edwards KR; Zhao Q
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
